产品: 磷酸化 Cyclin D3 (Thr283) 抗体
货号: AF3251
描述: Rabbit polyclonal antibody to Phospho-Cyclin D3 (Thr283)
应用: WB IHC IF/ICC
文献验证: WB
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken
蛋白号: P30281
RRID: AB_2834677

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1300 现货
 100ul RMB¥ 2400 现货
 200ul RMB¥ 3200 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Phospho-Cyclin D3 (Thr283) Antibody detects endogenous levels of Cyclin D3 only when phosphorylated at Threonine 283.
RRID:
AB_2834677
引用格式: Affinity Biosciences Cat# AF3251, RRID:AB_2834677.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

CCND 3; Ccnd3; CCND3_HUMAN; CyclinD3; D3 type cyclin; G1 S specific cyclin D3; G1/S specific cyclin D3; G1/S-specific cyclin-D3;

抗原和靶标

免疫原:

A synthesized peptide derived from human Cyclin D3 around the phosphorylation site of Thr283.

基因/基因ID:
描述:
CCND3 Regulatory component of the cyclin D3-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition.

研究领域

· Cellular Processes > Cell growth and death > Cell cycle.   (View pathway)

· Cellular Processes > Cell growth and death > p53 signaling pathway.   (View pathway)

· Cellular Processes > Cell growth and death > Cellular senescence.   (View pathway)

· Cellular Processes > Cellular community - eukaryotes > Focal adhesion.   (View pathway)

· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Wnt signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Hippo signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Jak-STAT signaling pathway.   (View pathway)

· Human Diseases > Infectious diseases: Viral > Measles.

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Overview > Viral carcinogenesis.

文献引用

1). Mechanism of D-type cyclin recognition by the AMBRA1 E3 ligase receptor. Science advances, 2025 (PubMed: 40408472) [IF=11.7]

Application: WB    Species: human    Sample:

Fig. 5. AMBRA1 mediates the ubiquitination of D-type cyclins. (A) Ubiquitination assay of AMBRA1WD40 mediated the polyubiquitination of TSF–cyclin D1, T286A mutant, and C-terminal truncation. The experiment was repeated independently three times with similar results. (B) Ubiquitination assay of AMBRA1WD40 mediated the polyubiquitination of TSF–cyclin D2/cyclin D2T280A and TSF–cyclin D3/cyclin D3T283A. The experiment was repeated independently three times with similar results. (C) In vitro pull-down experiment of GST–cyclin D1 with MBP-AMBRA1FL-His and H75A/R96A/W99A mutant. The cells were cotransfected with GST–cyclin D1, CDK4EE-His6, His6-DDB1, and MBP-AMBRA1FL-His or MBP-AMBRA1H75A/R96A/W99A-His mutant. The experiment was repeated at least three times and visualized by Western blotting. (D) Ubiquitination assay of AMBRA1FL mediated the polyubiquitination of TSF–D-type cyclins and threonine phosphorylation site mutants. The experiment was repeated independently three times with similar results. (E) Ubiquitination assay of AMBRA1FL mediated the polyubiquitination of CDK4 was detected. The experiment was repeated independently three times with similar results. (F) Ubiquitination assay of AMBRA1FL mediated the polyubiquitination of GST–cyclin D1 C terminus, the hemagglutinin (HA)–ubiquitin, and K269R mutant as negative control. The experiment was repeated independently three times with similar results. (G) Ubiquitination assay of AMBRA1 mediated the polyubiquitination of GST–cyclin D1 C termini. Asterisk indicates the nonspecific band. The experiment was repeated independently three times with similar results. (H) Ubiquitination assay of AMBRA1WD40 WT and key binding site mutants mediated the polyubiquitination of cyclin D1. The results were analyzed by Western blotting. The experiment was repeated independently three times with similar results.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.